Department of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, 240 E. 38th St., 14th floor, New York, NY, 10016, USA.
Curr Oncol Rep. 2024 Aug;26(8):865-879. doi: 10.1007/s11912-024-01553-2. Epub 2024 May 30.
Up to 60% of breast cancer patients continue to experience pain three months or more after surgery, with 15 to 25% reporting moderate to severe pain. Post-mastectomy pain syndrome (PMPS) places a high burden on patients. We reviewed recent studies on perioperative interventions to prevent PMPS incidence and severity.
Recent studies on pharmacologic and regional anesthetic interventions were reviewed. Only nine of the twenty-three studies included reported a significant improvement in PMPS incidence and/or severity, sometimes with mixed results for similar interventions. Evidence for prevention of PMPS is mixed. Further investigation of impact of variations in dosing is warranted. In addition, promising newer interventions for prevention of PMPS such as cryoneurolysis of intercostal nerves and stellate ganglion block need confirmatory studies.
高达 60%的乳腺癌患者在手术后三个月或更长时间仍持续存在疼痛,15%至 25%的患者报告有中度至重度疼痛。乳房切除术后疼痛综合征(PMPS)给患者带来了沉重的负担。我们回顾了最近关于预防 PMPS 发生率和严重程度的围手术期干预措施的研究。
对药物和区域麻醉干预的研究进行了回顾。在 23 项研究中,只有 9 项报告称 PMPS 的发生率和/或严重程度有显著改善,有时类似的干预措施也会出现混合结果。预防 PMPS 的证据参差不齐。进一步研究剂量变化的影响是必要的。此外,冷冻神经松解术和星状神经节阻滞等用于预防 PMPS 的较新的有前途的干预措施需要进行确证性研究。